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Abstract
The p300 and CBP histone acetyltransferases are recruited to DNA double-strand break
(DSB) sites where they induce histone acetylation, thereby influencing the chromatin struc-
ture and DNA repair process. Whether p300/CBP at DSB sites also acetylate non-histone
proteins, and how their acetylation affects DSB repair, remain unknown. Here we show that
p300/CBP acetylate RAD52, a human homologous recombination (HR) DNA repair protein,
at DSB sites. Using in vitro acetylated RAD52, we identified 13 potential acetylation sites in
RAD52 by a mass spectrometry analysis. An immunofluorescence microscopy analysis
revealed that RAD52 acetylation at DSBs sites is counteracted by SIRT2- and SIRT3-
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mediated deacetylation, and that non-acetylated RAD52 initially accumulates at DSB sites,
but dissociates prematurely from them. In the absence of RAD52 acetylation, RAD51, which
plays a central role in HR, also dissociates prematurely from DSB sites, and hence HR is
impaired. Furthermore, inhibition of ataxia telangiectasia mutated (ATM) protein by siRNA
or inhibitor treatment demonstrated that the acetylation of RAD52 at DSB sites is dependent
on the ATM protein kinase activity, through the formation of RAD52, p300/CBP, SIRT2, and
SIRT3 foci at DSB sites. Our findings clarify the importance of RAD52 acetylation in HR and
its underlying mechanism.
Author summary
DNA double strand breaks (DSBs) are the most dangerous type of DNA damage in cells.
Homologous recombination (HR) is a DSB repair system in which a central player,
RAD51, functions with several proteins, including RAD52. DSBs activate the DNA dam-
age response signaling network, in which the ataxia telangiectasia mutated (ATM) protein
plays a chief role, by phosphorylating numerous target proteins. As compared to phos-
phorylated proteins, relatively few acetylated proteins have been functionally character-
ized in DNA repair. In addition, beyond the roles in phosphorylation signaling, much less
is known about whether ATM functions are linked with other protein modifications, such
as acetylation. Here, we found that RAD52 at DSB sites is acetylated by p300/CBP acetyl-
transferases and then deacetylated by SIRT2/SIRT3 deacetylases. RAD52 acetylation is
required for sustained RAD51 colocalization at DSB sites, and is therefore essential in HR.
ATM is required for the recruitment of RAD52, p300/CBP and SIRT2/SIRT3 to DSB sites,
and therefore is essential for RAD52 acetylation. Thus, the RAD52-acetylation state is crit-
ical for HR, and its regulation is linked to ATM signaling. Our work demonstrates the
importance of the regulation of RAD52 acetylation in HR and its underlying mechanism.
Introduction
Ionizing radiation (IR) induces deleterious DNA lesions, such as DNA double-strand breaks
(DSB). In response to DSBs, DNA damage response (DDR) signaling is induced. Ataxia telan-
giectasia mutated (ATM) protein kinase is one of the central players for phosphorylation-
mediated DDR signaling, which is activated at DSB sites and phosphorylates numerous pro-
teins, including the histone variant H2AX, and cell cycle checkpoint and DNA repair proteins
[1]. Homologous recombination (HR) is an important mechanism for the repair of DSBs [2].
HR repairs DSBs through DNA strand invasion and exchange, in which the damaged DNA
strand retrieves genetic information from an undamaged homologous DNA strand. After DSB
formation, HR is initiated by a 5’ to 3’ end resection generating 3’ single-stranded (ss) DNA
overhangs. In mammalian cells, DSB end resection is mediated by the MRE11-RAD50-NBS1
(MRN)-CtIP complex and the EXO1 protein [3,4,5]. Afterwards, replication protein A (RPA)
rapidly coats the 3’-overhang ssDNA regions, thereby removing secondary structures that
form on the ssDNA region. Subsequently, the RPA coating the ssDNA regions is displaced by
the RAD51 recombinase, to form a right-handed nucleoprotein filament. The RAD51 nucleo-
protein filament then catalyzes DNA strand invasion and exchange between ssDNA and the
homologous sequence within double-stranded (ds) DNA.
Acetylation of RAD52 in homologous recombination
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The replacement of RPA with RAD51 requires additional proteins, such as recombination
mediators, because prior binding of RPA to ssDNA inhibits the nucleation of RAD51 on
ssDNA. Biochemical studies using recombinant proteins demonstrated that the yeast Rad52
protein stimulates the Rad51-mediated displacement of RPA from ssDNA regions [6]. In the
mouse, the targeted inactivation of RAD52 reduces HR and may be involved in certain types of
DSB repair processes [7]. However, this mediator function of human RAD52 for the loading
of RAD51 onto the RPA-coated ssDNA region has never been demonstrated, despite extensive
biochemical analyses [2,8]. Instead, biochemical studies have revealed that the human BRCA2
protein, which does not have a yeast homologue, promotes the RAD51 nucleoprotein filament
formation on RPA-covered ssDNA in vitro [9,10]. Therefore, instead of RAD52, BRCA2 is
thought to mediate RAD51-dependent HR in human cells. This is supported by the fact that a
knockdown of BRCA2 in human cells decreases the efficiency of IR-induced RAD51 foci for-
mation. Interestingly, a RAD52 knockdown in BRCA2-knockdown or BRCA2-deficient cells
almost completely inhibits IR-induced RAD51 foci formation [11], which suggests that human
RAD52 could act as a RAD51 mediator or complement the RAD51-dependent pathway in
HR. Since most previous biochemical studies of RAD52 have utilized an unmodified, recombi-
nant RAD52 protein expressed in Escherichia coli, it is possible that a recombination mediator
activity of RAD52 might only be revealed upon post-translational modifications, as discussed
by San Filippo et al. [2].
RAD52 preferentially binds ssDNA [12] rapidly and tightly, by wrapping the ssDNA
around itself [13]. In contrast, RAD52 binds dsDNA slowly and weakly, but changes the
dsDNA mechanics probably by intercalating into the DNA helix [13]. RAD52 also interacts
with RPA and RAD51 [14,15]. Both yeast and human RAD52 exhibit ssDNA annealing activ-
ity [12,16], which may be required in the steps following strand invasion mediated by RAD51
[17,18], as well as in the RAD51-independent single-strand annealing (SSA) pathway [2].
Human RAD52 also has a D-loop formation activity [19]. Both human and yeast RAD52 are
multimeric proteins [6,20]. Three-dimensional reconstitution from electron microscopy
images revealed that full-length human RAD52 exists as a heptameric ring [21]. The crystal
structure of the amino (N)-terminal half of RAD52 revealed an undecameric ring with a highly
positively-charged groove outside the ring [22,23]. The N-terminal half of human RAD52
encompasses the catalytic domain for homologous pairing. Structure-based alanine scan muta-
genesis of the N-terminal half of RAD52 revealed that several lysine (K) residues within the
positively-charged groove are essential for DNA binding [22,24]. The carboxyl (C)-terminal
region of human RAD52 contains domains that interact with RAD51 and RPA.
Post-translational modifications, such as phosphorylation, ubiquitylation, small ubiquitin-
like modifier (SUMO)ylation, and acetylation, regulate biological processes by controlling a
wide variety of protein functions. Previously, some post-translational modifications of Rad52
were identified. Yeast Rad52 is modified by SUMO at the K10, K11, and K220 sites, and the
SUMOylation is induced by a treatment with DNA-damaging agents [25]. SUMOylation of
yeast Rad52 protects it from proteasomal degradation. Human RAD52 is also modified by
SUMO, but the SUMOylation sites of human RAD52 differ from those of yeast Rad52. The in
vitro SUMOylation sites of human RAD52 are K411, K412, and K414, which are located within
the putative nuclear localization signal near the C-terminus (Saito et al., 2010). SUMOylation
does not affect the biochemical activities of human RAD52, but mutations at SUMOylation
sites inhibit RAD52 nuclear localization [26]. Nuclear phosphatase and tensin homolog on
chromosome 10 (PTEN) was recently found to be involved in regulating RAD52 SUMOylation
[27]. PTEN is also modified by SUMOylation, which is involved in the exclusion of the protein
from the nucleus [28]. The function of the SUMOylation of human RAD52, however, remains
poorly understood. Human RAD52 is also phosphorylated at tyrosine (Y) 104 by c-ABL
Acetylation of RAD52 in homologous recombination
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tyrosine kinase upon exposure to IR, and the phosphorylation deficiency inhibits the IR-
induced foci formation of RAD52 [29]. Phosphorylation at Y104 enhances the ssDNA anneal-
ing activity of RAD52 by increasing the binding specificity for ssDNA [30]. No other post-
translational modifications of RAD52 have yet been identified.
Among the several post-translational modifications, acetylation occurs on specific lysine
residues and is catalyzed by histone acetyltransferases (HATs). Histones are well-known target
proteins for acetylation. Histone acetylation influences chromatin structure, thereby regulating
a wide variety of DNA transaction processes, such as transcription [31], DNA replication [32],
DNA recombination [33], and DNA repair [34]. HATs can also acetylate non-histone proteins,
including some DNA repair proteins [35,36]. During HR, CtIP is deacetylated by SIRT6 his-
tone deacetylase (HDAC), and deacetylation is required for DNA end-resection, although the
specific acetyltransferase for CtIP has not yet been identified [37]. The HATs, p300 and CBP,
accumulate at laser microirradiation- or I-SceI-induced DSB sites, and promote histone acety-
lation at DSB sites [34]. Whether the accumulated p300 and CBP at DSB sites also induce the
acetylation of non-histone proteins involved in DSB repair, however, is unclear.
Here, we provide evidence for human RAD52 acetylation by p300/CBP upon DSB induc-
tion, and its involvement in RAD51 localization at DSB sites during HR repair. We show how
HR is regulated via RAD52 acetylation and reveal the link between the acetylation event and
the ATM-dependent phosphorylation.
Results
Human RAD52 is acetylated by p300/CBP in vitro
The acetylation of non-histone DNA repair proteins has attracted recent attention [35,36,37].
We searched for new HAT substrates among human DNA repair proteins, and found that
human RAD52 interacted with CBP, one of the well-known HATs (Fig 1A). FLAG-tagged
CBP coimmunoprecipitated with RAD52, but not with the glutathione S-transferase (GST)
control. RAD52 also specifically interacted with p300, which is structurally and functionally
similar to CBP (S1A Fig). An in vitro acetylation assay was performed to examine whether
RAD52 is acetylated by either CBP or p300. DNA polymerase β was used as a positive acetyla-
tion control substrate [35]. Strikingly, the incubation of human RAD52 with p300 or CBP, in
the presence of acetyl CoA, promoted RAD52 acetylation, which was detected by immunoblot-
ting using an anti-acetyl lysine antibody (Fig 1B). RAD52 acetylation was also confirmed by an
in vitro acetylation assay using 14C-labeled acetyl CoA; the 14C-labeled acetyl group was trans-
ferred onto the ε-amino group of the lysine residue. Acetylation of RAD52 was specifically
detected when RAD52 was incubated with CBP (Fig 1C; lane 6) or p300 (S1B Fig; lane 6) in
the presence of 14C-labeled acetyl CoA. Notably, RAD52 was more efficiently acetylated than
the control substrate, DNA polymerase β (lane 3 in Fig 1C and S1B Fig). By contrast, neither
RAD51 nor DNA polymerase κ [38], which are key factors in homologous recombination, was
acetylated by CBP or p300 in vitro (S1C–S1E Fig).
Identification of acetylated sites of RAD52
To map the acetylated sites in RAD52, we performed an in vitro acetylation assay with the N-
or C-terminal half of RAD52 (Fig 1D and S1F Fig). Both RAD52 fragments were acetylated by
CBP or p300, although the C-terminal fragment of RAD52 (209–418) was more efficiently
acetylated. To identify the acetylated residues, we performed a liquid chromatography mass
spectrometry (LC-MS) analysis using in vitro acetylated full-length, N-terminal, and C-termi-
nal RAD52 fragments. We identified 11 acetylation sites in RAD52 (FL), and two additional
acetylation sites (K133, K177) in the C-terminally truncated RAD52 (N) (S1–S4 Tables and Fig
Acetylation of RAD52 in homologous recombination
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2A). We next purified two full-length RAD52 mutants, one containing arginine substitutions
at the 11 acetylation sites (11xR), and the other containing arginine substitutions at all 13 iden-
tified acetylation sites (13xR). Using 11xR and 13xR, we confirmed that the p300/CBP-medi-
ated acetylation of RAD52 was diminished when 11 or all 13 of the identified lysine residues
were mutated to arginine (Fig 2B). The identified sites are well conserved among different spe-
cies (S2 Fig). Lysines 411, 412, and 414 were previously identified as SUMOylation sites, and
overlap with the nuclear localization signal (NLS) [26]. Mutations at these SUMOylation sites
inhibited RAD52 nuclear localization. Another notable acetylation site is lysine 133, which is
an important site for DNA binding [24]. To study the RAD52 acetylation in detail, we used the
acetylation-deficient, lysine-to-arginine substituted mutants in in vivo studies (S3 Fig). The
11xR mutant and the unmodified RAD52 (Wt) displayed similar ssDNA binding activities,
suggesting that the multiple lysine to arginine substitutions do not affect the RAD52 activity
(S4A and S4B Fig).
Human RAD52 is acetylated in vivo
To examine whether RAD52 is acetylated in human cells, we expressed an N-terminally
FLAG-tagged RAD52 in human embryonic kidney 293 (HEK293) cells, and immunoprecipi-
tated RAD52 using anti-FLAG antibody-conjugated agarose. Overexpression of CBP induced
RAD52 acetylation, based on immunoblotting using an anti-acetyl lysine antibody (S5A Fig).
To evaluate the acetylation status and localization of RAD52 in vivo, we produced anti-ace-
tyl RAD52 antibodies against the acetylated lysine residues 274 or 323. The antibody specificity
for acetylated RAD52 was confirmed by comparison with the in vitro acetylated or non-acety-
lated RAD52 protein (Fig 3A and 3B). Immunoblotting with each antibody revealed a positive
reaction to the acetylated RAD52 protein (Fig 3A and 3B). We then used these anti-acetyl
RAD52 antibodies to examine whether the induction of DSBs changes the acetylation status of
RAD52 in cells. We used the chemical DSB inducer doxorubicin, because it constitutively pro-
duces DSBs in the cells, and thus we thought it may induce a stronger DSB signal. Doxorubicin
induced RAD52 acetylation in repair-proficient mesenchymal stem cells (MSCs; Fig 3C) [39].
A band shift of in vivo acetylated RAD52 was observed following doxorubicin treatment (Fig
3D). The migration distance of the in vitro acetylated RAD52 was indistinguishable from that
of the non-acetylated RAD52 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) (Fig 1B). This was not the case for the acetylated RAD52 produced in vivo (Fig
3A), raising the possibility that the in vivo acetylation induces additional modifications of
RAD52. Furthermore, we expressed a RAD52 construct in which 10 of the acetylation sites,
except for lysine 411, 412, and 414 involved in the nuclear localization of RAD52 [26], were
substituted with arginine (10xR; Fig 3E and S3 Fig), and performed immunoblotting analyses
to examine whether the mutations affect the interaction between RAD52 and the anti-acetyl
Fig 1. Human RAD52 is directly acetylated by p300/CBP in vitro. (A) Physical interaction of human RAD52 with CBP. The
RAD52 or GST protein was incubated with or without CBP-FLAG in buffer P, and a pull-down assay was performed as described in
the Supporting Materials and Methods. Input or immunoprecipitated (IP) proteins were detected by a mixture of anti-RAD52 and
anti-GST antibodies (top) or an anti-FLAG (M2) antibody (bottom). (B) RAD52 (0.2 μg; top) or DNA polymerase β (0.2 μg;
bottom) was incubated in 10 μl HAT buffer A containing 10 mM sodium butyrate and 0.4 μg acetyl coenzyme A (Ac-CoA) in the
absence (-) or presence of HATs (42.5 ng of FLAG-p300 or 275 ng of CBP-FLAG) at 30˚C for 90 min. Reaction mixtures were
subjected to immunoblotting analyses. (C, D) In vitro acetylation assays were performed as described in the Supporting Materials
and Methods, using HAT buffer A containing sodium butyrate. [14C]Ac-CoA was added where indicated. The reactions were
analyzed by Coomassie Brilliant Blue staining (left) or autoradiography (right). Acetylated proteins can be detected by
autoradiography. Bovine serum albumin (BSA), as a negative control of acetylation, was not detected in this assay. (C) RAD52
(3 μg), DNA polymerase β (3 μg), or BSA (3 μg) was incubated with CBP-FLAG (2 μg) where indicated. (D) RAD52 (FL, 2 μg),
RAD52 (N, 2 μg), or RAD52 (C, 2 μg) was incubated with CBP-FLAG (1 μg), as indicated.
https://doi.org/10.1371/journal.pgen.1007277.g001
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RAD52 antibody. We did not achieve a positive signal with the anti-acetyl RAD52 antibody
(K323) in the presence of the 10xR mutant (Fig 3E) or in the absence of RAD52-HA expression
by the vector (S6 Fig). These findings indicate that the anti-acetyl RAD52 antibody (K323) spe-
cifically detects and precisely evaluates the cellular acetylation status of RAD52. The anti-acetyl
Fig 2. Identification of human RAD52 acetylation sites. (A) Location of RAD52 acetylation sites identified by LC-MS analysis.
Acetylated amino acid residues, highly conserved region responsible for DNA binding and self-association, RPA binding domain
(RPA), RAD51 binding domain (RAD51), and NLS are indicated in the schematic representation. The RAD52 (11xR) and RAD52
(13xR) mutant proteins used in Fig 2B are shown as schematic representations. (B) In vitro acetylation assays were performed as
described in the Supporting Materials and Methods, using HAT buffer A containing sodium butyrate. RAD52 (Wt, 2 μg), RAD52
(11xR, 2 μg), or RAD52 (13xR, 2 μg) was incubated with CBP-FLAG (500 ng; left), FLAG-p300 (500 ng; right), and [14C] Ac-CoA
where indicated. The reactions were analyzed by Coomassie Brilliant Blue staining (upper) or autoradiography (bottom).
https://doi.org/10.1371/journal.pgen.1007277.g002
Acetylation of RAD52 in homologous recombination
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Fig 3. Human RAD52 is acetylated in vivo. (A, B) An in vitro acetylation assay was performed by incubating RAD52 (0.25 μg) in 10 μl HAT buffer A
containing 10 mM sodium butyrate, in the presence of 0.5 μg Ac-CoA and CBP-FLAG (54 ng), at 30˚C for 60 min. Unacetylated and acetylated RAD52
were subjected to immunoblotting analyses using the indicated antibodies. (C, D, E) Acetylation of the FLAG-RAD52-HA protein purified from MSCs
was detected as described in the Supporting Materials and Methods, using the indicated antibodies. The expression plasmid, pT-Rex-DEST30
Acetylation of RAD52 in homologous recombination
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RAD52 antibody (K274) also specifically detected the acetylation of RAD52, but the specificity
of the anti-acetyl RAD52 antibody (K323) against acetylated RAD52 was superior to that of
the anti-acetyl RAD52 antibody (K274) (Fig 3C and 3E).
To examine the RAD52 acetylation at DSB sites, MSCs expressing RAD52 (Wt) or the
RAD52 (10xR) mutant were irradiated with 8 Gy γ-rays and examined by an immunofluores-
cence approach. IR treatment transiently induces DSBs in cells, and thus IR is better suited for
examining the level of RAD52 acetylation as a function of time. RAD52 foci, which colocalize
with phosphorylated H2AX (γH2AX), were detected with both wild-type and mutant RAD52
(Fig 3F). In contrast, radiation-induced acetylated RAD52 (assessed using the anti-acetyl
RAD52 antibody) was only detected in cells expressing RAD52 (Wt) protein at 1 h after IR.
Acetylation of RAD52 (Wt) was not detected at 6 h after IR, suggesting that deacetylation of
RAD52 occurs between 1–6 h at DSB sites. Significant acetylated RAD52 signals were not
detected in cells expressing the RAD52 (10xR) protein throughout the time period studied,
indicating that the anti-acetyl RAD52 antibody specifically recognized acetylated RAD52 by
immunofluorescence. We also investigated the distribution of p300 and CBP in these irradi-
ated cells, and observed p300 and CBP foci, which colocalized with γH2AX, at 1 h and 6 h after
IR in human fetal lung fibroblast (MRC5) cells (S5B and S5C Fig). This finding is consistent
with a previous report that describes the recruitment of p300/CBP to laser-induced DSB sites
[34]. The p300 and CBP foci also colocalized with the RAD52 foci, as observed at 1 h or 6 h
after IR in HEK293 cells (S5D and S5E Fig). In addition, the specific interaction of p300 or
CBP with RAD52, but not GST, was detected by dithiobis succinimidyl propionate (DSP)-
mediated in vivo cross-linking experiments in exogenously p300- or CBP-overexpressing
HEK293 cells (S5F and S5G Fig). The interaction of p300 with RAD52 was increased upon
doxorubicin treatment (S5F Fig). Finally, the knockdown of both p300 and CBP inhibited the
DSB-induced acetylation of RAD52 (Fig 3G and 3H; S5H and S5I Fig). Taken together, our
findings indicate that IR induces p300/CBP foci formation and acetylation of RAD52 at DSB
sites.
RAD52 acetylation is inhibited by its binding to DNA and RPA
By analogy with yeast Rad52, human RAD52 is reported to bind to RPA-coated ssDNA follo-
wig resection. RAD52 is also thought to bind to both ssDNA and dsDNA during the DNA
strand exchange reaction. The N-terminal half of RAD52 contains a DNA binding region,
whereas the C-terminal half contains an RPA binding region. Therefore, using an in vitro acet-
ylation assay, we examined whether RAD52 binding to DNA or RPA affects the level of its
acetylation. The addition of linear (L) ssDNA to the reaction mixture for the in vitro acetyla-
tion of RAD52 (FL) decreased the level of RAD52 acetylation (Fig 4A). The addition of circular
(C) or linear dsDNA also decreased the acetylation of RAD52 (FL), but less than that of the lin-
ear ssDNA. Auto-acetylation of CBP was not affected by the addition of these DNA substrates.
The N-terminal half of RAD52, RAD52 (1–212), contains the DNA-binding domain (Fig 2A).
The acetylation of RAD52 (1–212) was completely inhibited by the addition of any one of the
containing FLAG-RAD52 (Wt)-HA or FLAG-RAD52 (10xR)-HA, was transfected into the cells. FLAG-RAD52-HA was purified from cell extracts 24 h
after transfection. Cells were treated with doxorubicin for 2 h, as indicated. (D) The red arrow indicates the mobility-shifted band. (F) MSCs expressing
FLAG-RAD52 (Wt)-HA or FLAG-RAD52 (10xR)-HA were unirradiated or irradiated with γ-rays (8 Gy). At the indicated time after irradiation, the
cells were subjected to immunofluorescent staining with anti-HA (green), anti-γH2AX (red), and anti-acetylated RAD52 at K323 (blue or white)
antibodies. (G, H) T-Rex-293 cells expressing FLAG-RAD52-HA were transfected with either a negative control siRNA or mixture of p300 and CBP-
specific siRNAs. At 24 h after transfection, the cells were treated with doxorubicin for 2 h. Immunoprecipitated FLAG-RAD52-HA proteins from the
cell extracts were subjected to immunoblotting analyses with the indicated antibodies. (C, E, G, H) The relative band intensities normalized to those of
the HA bands are shown below the immunoblots.
https://doi.org/10.1371/journal.pgen.1007277.g003
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Fig 4. In vitro acetylation of RAD52 is inhibited in the presence of DNA or RPA. In vitro acetylation assays were
performed as described in the Supporting Materials and Methods, using HAT buffer A containing sodium butyrate.
The full-length (A), N-terminal half (B), or C-terminal half (C, D) of RAD52 (2 μg) was incubated with [14C] Ac-CoA
and CBP-FLAG (500 ng). (A, B, C) RAD52 was premixed with 8,500 pmol (in nucleotides) of linear ssDNA, circular
Acetylation of RAD52 in homologous recombination
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007277 March 28, 2018 10 / 38
DNA substrates (Fig 4B), whereas the acetylation of the C-terminal half of RAD52, RAD52
(209–418), was not affected by the addition of the DNA substrates (Fig 4C). RAD52 (209–418)
contains the RPA-binding domain (Fig 2A), and RAD52 (209–418) acetylation was inhibited
by the addition of RPA in a dose-dependent manner (Fig 4D). Therefore, these results suggest
that at least some of the acetylation sites of RAD52 are located at the DNA and RPA interacting
surfaces.
SIRT2 and SIRT3 are involved in the deacetylation of acetylated RAD52 at
DSB sites
HATs and HDACs regulate protein acetylation levels. Therefore, we next examined which
HDACs are involved in the deacetylation of acetylated RAD52. After RAD52 acetylation by
CBP in vitro, linear ssDNA was added to the reaction mixture to inhibit further RAD52 acety-
lation. The reaction mixture was divided, and each sample was subjected to an in vitro deacety-
lation assay using recombinant HDAC proteins. Among the HDAC proteins examined, the
recombinant HDAC3/NCOR2 complex, SIRT2, and SIRT3 proteins deacetylated the acety-
lated RAD52 (Fig 5).
Since the acetylated RAD52 appeared to be deacetylated at DSB sites after IR (Fig 3F), we
examined whether the identified HDACs for RAD52 were recruited to DSB sites after IR. We
observed that SIRT2 and SIRT3, but not HDAC3, colocalized with γH2AX and/or RAD52 at 1
h after IR (Fig 6A–6F). The SIRT2 and SIRT3 foci colocalized with γH2AX and RAD52 even at
6 h after IR (Fig 6A, 6B, 6E and 6F), suggesting that SIRT2 and/or SIRT3 are involved in the
deacetylation of acetylated RAD52 at DSB sites. Therefore, we examined whether the knock-
down of Sirt2 or Sirt3 affects the decrease of RAD52 acetylation observed at 6 h after IR. The
expression of SIRT2 and SIRT3 was effectively reduced by a small interfering (si)RNA treat-
ment (Fig 7A and 7B, S7A and S7B Fig). Importantly, acetylated RAD52 was maintained at
DSB sites even at 6 h after IR following SIRT2 or SIRT3 depletion (Fig 7C). Therefore, our
results strongly suggest that SIRT2 and SIRT3 deacetylate RAD52 at DSB sites.
dsDNA, or linear dsDNA before the addition of CBP and Ac-CoA to the reaction mixture. (D) RAD52 was premixed
with the indicated amount of RPA, before adding CBP and Ac-CoA to the reaction mixture.
https://doi.org/10.1371/journal.pgen.1007277.g004
Fig 5. Screening of HDACs for RAD52 in vitro. In vitro HDAC assays were performed as described in the Supporting
Materials and Methods, using acetylated RAD52 and recombinant HDAC proteins. Reaction mixtures were analyzed
by immunoblotting with an anti-acetyl lysine antibody (top) or an anti-RAD52 (bottom) antibody.
https://doi.org/10.1371/journal.pgen.1007277.g005
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RAD52 acetylation is required for efficient accumulation of RAD52 at DSB
sites
The RAD52 protein localized to DSB sites after IR (Figs 3F and 8A). Therefore, we examined
whether lysine to arginine substitutions at the acetylation sites influence the accumulation of
RAD52 at DSB sites. The RAD52 (13xR) mutant (with arginine substituted for lysine at the 13
identified acetylated lysine sites, including 3 substitutions in the C-terminal NLS sequence; S3
Fig) localized to the cytoplasm rather than the nucleus, independently of IR (Fig 8B). Interest-
ingly, the RAD52 (13xR) foci colocalized with γ-tubulin, indicating that RAD52 can localize to
the centrosome.
To examine the acetylation-deficient effect of the RAD52 (13xR) mutant in the nucleus, we
constructed a RAD52 (13xR) mutant with an N-terminally fused NLS (NLS-RAD52 [13xR]; S3
Fig). NLS-RAD52 (13xR) was detected in the nucleus, but did not colocalize with γH2AX in
MRC5 cells at 6 h after IR (Fig 8C). We next examined the kinetics of the colocalization of
RAD52 (Wt) and RAD52 acetylation-deficient mutants with γH2AX in irradiated MSCs. The
Fig 6. Colocalization of SIRT2 and SIIR3 with RAD52 at IR-induced DSB sites. (A, B, C) T-Rex-293 cells expressing
FLAG-RAD52 (Wt)-HA were unirradiated or irradiated with γ-rays (8 Gy), and subjected to immunofluorescent staining at the
indicated time after IR, using (A) anti-HA (green), anti-γH2AX (red), and anti-SIRT2 (blue or white) antibodies. (B) Anti-HA
(green), anti-γH2AX (red), and anti-SIRT3 (blue or white) antibodies were used. (C) An anti-HA (green) antibody, an anti-
HDAC3 (red) antibody, and DAPI (blue) were used. (D, E, F) T-Rex-293 cells expressing HDAC3-HA (D), SIRT2-HA (E) or
SIRT3-HA (F) were unirradiated or irradiated with γ-rays (8 Gy). At the indicated time after irradiation, the cells were
subjected to immunofluorescent staining with an anti-HA (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue).
https://doi.org/10.1371/journal.pgen.1007277.g006
Fig 7. SIRT2 and SIRT3 are involved in the deacetylation of RAD52 at DSB sites. T-Rex-293 cells expressing FLAG-RAD52 (Wt)-HA
were treated with either control siRNA (C), SIRT2-specific siRNA (siSIRT2), SIRT3-specific siRNA (siSIRT3), or both siRNAs (siSIRT2 &
3), as described in the Supporting Materials and Methods. (A, B) Cell extracts were prepared 48 h after siRNA transfection, and were
subjected to immunoblotting analyses with the indicated antibodies. (C) Cells were irradiated with γ-rays (8 Gy) 48 h after siRNA
transfection. At 1 h or 6 h after irradiation, cells were subjected to immunofluorescent staining with anti-HA (green), anti-γH2AX (red),
and anti-acetylated RAD52 at K323 (blue or white) antibodies.
https://doi.org/10.1371/journal.pgen.1007277.g007
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Fig 8. Effect of 13xR mutation on ionizing radiation-induced foci formation by RAD52. (A, B) MRC5V1-TR cells
were unirradiated or irradiated with γ-rays (8 Gy), and subjected to immunofluorescent staining at the indicated time
after irradiation. (A) Cells expressing FLAG-RAD52 (Wt)-HA were used. An anti-HA (green) antibody, an anti-
γH2AX (red) antibody, and 4’,6-diamidino-2-phenylindole (DAPI, blue) were used for immunofluorescent staining.
(B) Cells expressing FLAG-RAD52 (13xR)-HA were used. An anti-HA (green) antibody, an anti-γ-tubulin (red)
antibody, and DAPI (blue) were used for immunofluorescent staining. (C) MRC5V1-TR cells expressing
FLAG-NLS-RAD52 (Wt)-HA or FLAG-NLS-RAD52 (13xR)-HA were irradiated with γ-rays (8 Gy), and subjected to
immunofluorescent staining 6 h after irradiation. An anti-HA (green) antibody, an anti-γH2AX (red) antibody, and
DAPI (blue) were used for immunofluorescent staining, and the overlaid images are shown.
https://doi.org/10.1371/journal.pgen.1007277.g008
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control NLS-RAD52 (Wt) foci colocalized with γH2AX for 6 h after IR. In contrast, the
NLS-RAD52 (13xR) foci initially colocalized with γH2AX, but then dissociated from γH2AX
within 2 h after IR (Fig 9A and 9C). The RAD52 C-terminal region, including the acetylation
sites K411, 412, and 414, is known to be essential for the nuclear localization of RAD52. There-
fore, we next used the RAD52 (10xR) mutant harboring a normal NLS sequence for analyzing
the acetylation effects of RAD52 on IR-induced foci-formation at DSB sites in cells. The
RAD52 (10xR) mutant foci similarly showed an initial colocalization with γH2AX, followed by
an early dissociation (Fig 9B and 9D). Strikingly, during the first 30 min or 1 h after γ-irradia-
tion, both NLS-RAD52 (13xR) and RAD52 (10xR) showed clear colocalization with γH2AX
(Fig 9A–9D).
In order to confirm the effect of the 10xR mutation on the cellular localization of RAD52
expressed by the native promoter, we generated RAD52 (Wt or 10xR) knock-in cells by using
CRISPR/Cas9-mediated genome editing. The DNA donor plasmid shown in S9 Fig was con-
structed by the Multisite Gateway method, and was co-transfected with CRISPR Nuclease Vec-
tor plasmids into HeLa pDR-GFP or HEK293 cells. The expression of the HA-tagged RAD52
proteins from the native promoter was confirmed by an immunoblotting analysis (S9F and
S9G Fig). We then used the knock-in cells for an immunostaining analysis. In order to deplete
the RAD52 protein expressed from the untargeted allele, the knock-in cells were treated with
an siRNA targeted to the 3’UTR region of RAD52 (S7C Fig). Consistent with the results
described above, the colocalization of RAD52 with γH2AX foci was decreased in the 10xR
mutant at 6h after irradiation, whereas both the Wt and 10xR RAD52 proteins colocalized
with γH2AX at 1h after irradiation (S10A and S10B Fig).
To clarify the critical acetylation sites involved in this colocalization defect, we further
examined various RAD52 proteins mutated in several functional domains, such as the highly
conserved region (K133R, K133/K177R), the RPA binding region (K262R), and the RAD51
binding region (K323R), and also mutated residues outside the domains (190/192R). We also
used the RAD52 (8xR) mutant containing multiple mutations, except in the highly conserved
region and the C-terminal NLS region (S3 Fig). In contrast to the results obtained with the
NLS-RAD52 (13xR) and RAD52 (10xR) mutants, the colocalization of these RAD52 mutants
(K133R, K133/177R, K190/192R, K262R, K323R, and 8xR) with γH2AX was not affected after
γ-irradiation (Fig 10A and 10B), indicating that this defect is associated with all of the acetyla-
tion sites except for those in the C-terminal NLS region. These findings demonstrate that
RAD52 acetylation is required for its sustained retention at DSB sites.
DSB-induced acetylation of RAD52 is triggered by ATM
ATM is a pivotal mediator of signal transduction in response to DSBs. As RAD52 acetylation
was induced by DSBs, we examined whether its acetylation was triggered by ATM. KU55933 is
a potent and specific ATM kinase inhibitor (ATMi). To verify the functionality of the inhibi-
tor, we observed that the ATM-mediated phosphorylation of CHK2 on threonine 68 (T68)
was inhibited in the KU55933-treated cells used in our present study. We found that the doxo-
rubicin-induced acetylation of RAD52 was inhibited by the KU55933 (ATMi) treatment (Fig
11A). Consistent with this result, the knockdown of ATM by siRNA treatment decreased the
doxorubicin-induced acetylation of RAD52 (Fig 11B, 11C and 11D).
The IR-induced acetylation of RAD52 was also inhibited by the treatment with KU55933
(ATMi) (Fig 11E). Notably, the ATM inhibition with KU55933 (ATMi) did not completely
diminish the γH2AX foci formation, consistent with the previous findings that the IR-induced
phosphorylation of H2AX can be redundantly affected by ATM or DNA-PK [40]. These
γH2AX foci did not colocalize with the RAD52 foci, indicating that the treatment with
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Fig 9. Effect of acetylation-deficient mutations on ionizing radiation-induced foci formation by RAD52. (A, B) MSCs stably
expressing FLAG-RAD52-HA proteins were irradiated with γ-rays (8 Gy). At the indicated time after irradiation, the cells were
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subjected to immunofluorescent staining with an anti-HA (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). (A) MSCs
expressing NLS-RAD52 (Wt) or NLS-RAD52 (13xR) were used. (B) MSCs expressing RAD52 (Wt) or RAD52 (10xR) were used. (C, D)
The percentages of RAD52 foci colocalized with γH2AX were calculated, as described in the Supporting Materials and Methods. Error
bars indicate the standard error of the mean. Asterisks indicate statistically significant differences between the indicated pairs of groups
(, p<0.001 by t-test). (E) The number of γH2AX foci per cell was counted in MSCs expressing RAD52 (Wt) or RAD52 (10xR) at the
indicated time after irradiation with γ-rays (8 Gy), as described in the Supporting Materials and Methods (N.S., not significant by t-test).
https://doi.org/10.1371/journal.pgen.1007277.g009
Fig 10. IR-induced foci formation of RAD52 acetylation-site mutant proteins. (A, B) MSCs (A) or T-Rex-293
(HEK293) cells (B) expressing FLAG-RAD52 (Wt or the indicated mutants)-HA were irradiated with γ-rays (8 Gy),
and subjected to immunofluorescent staining 6 h after irradiation. An anti-HA (green) antibody, an anti-γH2AX (red)
antibody, and DAPI (blue) were used for immunofluorescent staining.
https://doi.org/10.1371/journal.pgen.1007277.g010
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Fig 11. ATM inhibition impedes acetylation of human RAD52 and its recruitment at IR-induced DSB sites. (A) MSCs were
transfected with the expression plasmid pT-Rex-DEST30, containing FLAG-RAD52 (Wt)-HA. Cells were treated with doxorubicin for 2 h
at 24 h after transfection. Where indicated, KU55933 (ATMi) was added to the cells at 1 h before the addition of doxorubicin.
Immunoprecipitated FLAG-RAD52-HA proteins from the cell extracts were subsequently subjected to immunoblotting analyses with anti-
Ac-RAD52 (K274), anti-Ac-RAD52 (K323) and anti-HA antibodies. The cell extracts before the immunoprecipitation were also subjected
to immunoblotting analyses with anti-phospho-CHK2-T68, anti-CHK2, and anti-GAPDH antibodies. The relative band intensities
normalized to those of the HA bands are shown. (B, C, D) MRC5 V1 cells were co-transfected with pT-Rex-DEST30 containing
FLAG-RAD52 (Wt)-HA and either control or ATM-specific siRNA, as described in the Supporting Materials and Methods. Cell extracts
were prepared 24 h after transfection. (B) Cell extracts were subjected to immunoblotting analyses with the indicated antibodies. (C, D)
Where indicated, the cells were treated with doxorubicin for 2 h before preparing the cell extracts. Immunoprecipitated FLAG-RAD52-HA
proteins from the cell extracts were subjected to immunoblotting analysis with the indicated antibodies. The relative band intensities
normalized to those of the M5 bands (C) or to the HA bands (D) are shown. (E, F) Recruitment of RAD52 to DSBs is dependent on ATM.
(E) T-Rex-293 cells expressing FLAG-RAD52 (Wt)-HA were irradiated with γ-rays (8 Gy). The KU55933 solution or the same volume of
DMSO was added to the cells 1 h before irradiation. At 1 h after irradiation, the cells were subjected to immunofluorescent staining.
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KU55933 (ATMi) inhibited the accumulation of RAD52 at DSB sites (Fig 11E and 11F). The
IR-induced accumulation of both p300 and CBP at DSB sites was inhibited by the treatment
with KU55933 (ATMi) in MRC5 cells (Fig 12A–12D). ATM is involved in the DNA damage-
induced phosphorylation of p300 at serine 106 (S106) [41]. We used p300 mutant proteins in
which S106 was substituted with alanine (S106A) or aspartic acid (S106D), which mimics the
phosphorylated state (Fig 12E). Both mutant proteins colocalized with γH2AX after IR, sug-
gesting that the ATM-mediated phosphorylation of p300 at the S106 site is not involved in its
colocalization at DSB sites. The colocalization of these two mutant proteins with γH2AX was
inhibited by KU55933 (ATMi). Interestingly, the radiation-induced accumulation of SIRT2
and SIRT3 at DSB sites was also inhibited by the treatment with KU55933 (ATMi) (Fig 13A–
13E). These ATM-associated events were not caused by non-specific effects, because the colo-
calization of 53BP1 with γH2AX was not inhibited by KU55933 (ATMi) (Fig 13F). The num-
ber of foci of RAD52, p300, CBP, SIRT2, and SIRT3 decreased in the presence of KU55933
(ATMi) (Figs 11F, 12C, 12D, 13C and 13D), whereas the cellular levels of these proteins did
not significantly change (S8A–S8E Fig). Thus, ATM inhibition prevents the accumulation of
RAD52, p300/CBP, and SIRT2/SIRT3 at DSB sites, thereby causing the intra-cellular diffusion
of these proteins, even after IR treatment. Therefore, our results suggest that the interaction of
RAD52 with p300 and CBP will be reduced by ATM inhibition, thereby decreasing the acetyla-
tion of RAD52. Taken together, our results indicate that the DSB-induced acetylation of
RAD52 occurs in the vicinity of DSB sites in an ATM-associated manner.
RAD52 acetylation is required for sustained colocalization of RAD51 at
DSB sites
We next examined whether RAD52 acetylation influences the accumulation of the RAD52-as-
sociated proteins, RPA and RAD51, at DSB sites. Expression of the RAD52 (10xR) mutant pro-
tein disrupted the IR-induced colocalization of RAD51 with γH2AX at 6 h in MSCs (Fig 14A
and 14B) and at 4 h in HEK293 cells (Fig 14C and 14D). Furthermore, RAD52 (10xR) mutant
expression in MSCs did not affect RAD51 foci formation or colocalization with γH2AX from
0.5 to 2 h after IR (Fig 14E). A time course experiment revealed that RAD51 colocalized with
γH2AX at 2 h after irradiation in both RAD52 (Wt) and RAD52 (10xR)-expressing HEK293
knock-in cells, with no significant difference (Fig 15A and 15B). Thereafter, at 4 and 6 h after
irradiation, the colocalization decreased only in the RAD52 (10xR)-expressing cells (Fig 15A
and 15B). These findings suggest that RAD52 acetylation is dispensable for the initial loading
of RAD51 at DSB sites, but is required for the sustained retention of RAD51 at DSB sites.
If the DNA resection is affected by RAD52 acetylation, then RPA foci formation should
also be affected. However, the expression of the RAD52 (10xR) mutant protein did not affect
the colocalization of RPA with γH2AX (Fig 16A). Therefore, our result suggests that DNA
resection is not affected by RAD52 acetylation. Previously, BRCA1 was demonstrated to func-
tion in the loading of RAD51 at DSB sites via the PALB2-mediated interaction with BRCA2
[42]. IR-induced phosphorylated BRCA1 foci were observed at DSB sites in RAD52 (10xR)
and NLS-RAD52 (13xR)-expressing cells (Fig 16B). These findings suggest that the non-acety-
lated RAD52 protein disturbs the colocalization of RAD51 at DSB sites, but does not influence
Immunofluorescent images with anti-HA (green), anti-γH2AX (red), and anti-acetylated RAD52 at K323 (blue or white) antibodies. (F)
The percentages of γH2AX foci colocalized with RAD52 in Fig 11E were calculated, as described in the Supporting Materials and Methods,
and are shown in the graph. The numbers of protein foci per cell are also shown in the graph. Error bars indicate the standard error of the
mean. Asterisks indicate statistically significant differences between the indicated pairs of groups (, p<0.001 by t-test).
https://doi.org/10.1371/journal.pgen.1007277.g011
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BRCA1 foci formation. These results are consistent with the aforementioned finding that the
initial loading of RAD51 at DSB sites was not affected by RAD52 acetylation.
Acetylation of RAD52 is required for HR repair
RAD52 depletion is reportedly synthetically lethal with the BRCA2 deficiency, and inhibits cell
growth in BRCA2-deficient cells [11]. Therefore, we examined whether BRCA2 depletion also
Fig 12. ATM inhibition impedes the recruitment of p300/CBP at IR-induced DSB sites. (A, B) MRC5V1 cells were transfected with the
expression plasmid for wild-type (Wt) HA-p300 (A) or CBP-HA (B). (E) MRC5V1 cells were transfected with the expression plasmid for either HA-
p300 S106A or HA-p300 S106D. (A, B, E) At 24 h after transfection, the KU55933 (ATMi) solution or the same volume of DMSO was added to cells
1 h before irradiation with γ-rays (8 Gy). At 1 h after irradiation, the cells were subjected to immunofluorescent staining. Immunofluorescent
images with an anti-HA (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). (C, D) The percentages of γH2AX foci colocalization
with p300 (C) or CBP (D) in Fig 12A and 12B were calculated, as described in the Supporting Materials and Methods, and are shown in the graphs.
The numbers of protein foci per cell are also shown in the graphs. Error bars indicate the standard error of the mean. Asterisks indicate statistically
significant differences between the indicated pairs of groups (, p<0.001 by t-test).
https://doi.org/10.1371/journal.pgen.1007277.g012
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inhibits cell growth in RAD52 (10xR)-expressing cells. BRCA2 depletion inhibited cell growth
in RAD52 (10xR)-expressing cells, but not in RAD52 (Wt)-expressing cells (Fig 17A).
Expression of the RAD52 (10xR) mutant did not affect the γH2AX foci formation after irra-
diation (Fig 9B and 9E). This result might be due to the existence of a backup DSB repair
Fig 13. ATM inhibition impedes the recruitment of SIRT2/SIRT3, but not 53BP1, at IR-induced DSB sites. (A, B) T-Rex-293 cells
expressing SIRT2-HA (A), or SIRT3-HA (B) were irradiated with γ-rays (8 Gy). The KU55933 (ATMi) solution or the same volume of DMSO
was added to the cells 1 h before irradiation. At 1 h after irradiation, the cells were subjected to immunofluorescent staining. Immunofluorescent
images with an anti-HA (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). (C, D) The percentages of γH2AX foci colocalization
with SIRT2 (C) or SIRT3 (D) in Fig 13A and 13B were calculated, as described in the Supporting Materials and Methods, and are shown in the
graphs. The numbers of protein foci per cell are also shown in the graphs. Error bars indicate the standard error of the mean. Asterisks indicate
statistically significant differences between the indicated pairs of groups (, p<0.001 by t-test). (E, F) The KU55933 solution or the same
volume of DMSO was added to T-Rex-293 cells, 1 h before irradiation with γ-rays (8 Gy). (E) Cells were subjected to immunofluorescent
staining at 1 h after irradiation with an anti-SIRT3 (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). (F) Cells were subjected to
immunofluorescent staining at 1 h after irradiation with an anti-53BP1 (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). As a
control, unirradiated cells (0 Gy) were used.
https://doi.org/10.1371/journal.pgen.1007277.g013
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Fig 14. Colocalization of RAD51 foci at DSB sites is inhibited in cells expressing RAD52 (10xR) acetylation-deficient
mutant protein. (A, B) MSCs stably expressing the indicated FLAG-RAD52-HA proteins were irradiated with γ-rays (8 Gy),
and subjected to immunofluorescent staining 6 h after irradiation. (A) Immunofluorescent images with anti-HA (green), anti-
γH2AX (red), and anti-RAD51 (blue) antibodies are shown. (B) The percentages of RAD51 foci colocalized with γH2AX were
calculated, as described in the Supporting Materials and Methods. Error bars indicate the standard error of the mean. Asterisks
indicate statistically significant differences between the FLAG-RAD52 (Wt)-HA expressing cells and the FLAG-RAD52 (10xR)-
HA expressing cells (, p<0.001 by t-test). (C) T-Rex-293 (HEK293) cells stably integrated with pT-Rex-DEST30 containing
FLAG-RAD52 (Wt or 10xR)-HA were cultured in the absence of a tetracycline inducer. As a negative control (-), T-Rex-293
cells that did not contain the expression vector were used. Cell extracts were subjected to immunoblotting analyses with the
indicated antibodies. (D) T-Rex-293 (HEK293) cells expressing FLAG-RAD52 (Wt or 10xR)-HA were irradiated with γ-rays (8
Gy), and subjected to immunofluorescent staining 4 h after irradiation. Immunofluorescent images with anti-γH2AX (red) and
anti-RAD51 (blue or white) antibodies are shown. (E) MSCs stably expressing FLAG-RAD52 (Wt or 10xR)-HA were irradiated
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system by the NHEJ pathway, and is consistent with the previous report showing that the inac-
tivation of mouse RAD52 reduces HR, but does not affect the resistance to ionizing radiation
[7]. However, the NHEJ pathway is dispensable for the repair of cross-linking DNA damage,
but the HR pathway is required for its repair with the Fanconi anemia DNA repair pathway
[44]. In the survival assay of cells treated with the DNA cross-linker cisplatin, the RAD52
(10xR)-expressing cells were more sensitive to cisplatin than the RAD52 (Wt)-expressing cells
with γ-rays (8 Gy), and subjected to immunofluorescent staining 0.5 or 2 h after irradiation. Immunofluorescent images with
anti-γH2AX (red) and anti-RAD51 (blue or white) antibodies are shown.
https://doi.org/10.1371/journal.pgen.1007277.g014
Fig 15. A time course analysis of RAD51 foci colocalization with γH2AX foci in cells expressing RAD52 Wt or 10xR mutant protein.
(A, B) RAD52 (Wt or 10xR) knock-in HEK293 cells, as shown in S9 Fig, were used. The cells were treated with siRNA (siRAD52 (3’UTR
#1)) 2 days before irradiation. (A) At the indicated time after irradiation with γ-rays (8 Gy), the cells were subjected to immunofluorescent
staining with an anti-RAD51 (green) antibody, an anti-γH2AX (red) antibody, and DAPI (blue). (B) The percentages of RAD51 foci
colocalized with γH2AX were calculated, as described in the Supporting Materials and Methods. Error bars indicate the standard error of
the mean. Asterisks indicate statistically significant differences between the FLAG-RAD52 (Wt)-HA expressing cells and the FLAG-RAD52
(10xR)-HA expressing cells (N.S., not significant; , p<0.001 by t-test).
https://doi.org/10.1371/journal.pgen.1007277.g015
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(Fig 17B). These results suggest that the acetylation of RAD52 is involved in HR repair. There-
fore, we next examined whether the expression of the RAD52 (10xR) mutant affects the HR
efficacy. We quantified IR-induced sister chromatid exchanges in HEK293 cells expressing an
empty vector or a vector encoding RAD52 (Wt) or RAD52 (10xR). Expression of RAD52 (Wt)
did not influence the IR-induced sister chromatid exchanges, whereas the RAD52 (10xR)
mutant expression decreased the frequency of sister chromatid exchanges (Fig 17C).
In order to confirm the requirement of RAD52 acetylation for HR repair, we used a
reporter assay with a cell line bearing a direct repeat green fluorescent protein (DR-GFP)
reporter cassette [43,45,46,47]. The DR-GFP reporter cassette comprises two inactive GFP
genes in a direct repeat orientation. One of the genes, SceGFP, contains an I-SceI cleavage site
that is absent in the human genome. The other gene, iGFP, comprises the internal GFP frag-
ment. HR repair between SceGFP and iGFP is induced when a specific DSB at the I-SceI site is
introduced by the expression of I-SceI endonuclease. Since HR repair generates an intact GFP
gene, the HR repair efficiency can be monitored as the frequency of GFP-positive cells (Fig
18A).
Fig 16. The RAD52 (10xR) mutant protein does not inhibit the formation of replication protein A (RPA) and
BRCA1 foci. (A) T-Rex-293 (HEK293) cells expressing FLAG-RAD52 (Wt or 10xR)-HA were irradiated with γ-rays (8
Gy), and subjected to immunofluorescent staining 4 h after irradiation. Immunofluorescent images with anti-HA
(green), anti-γH2AX (red), and anti-RPA1 (blue or white) antibodies are shown. (B) MSCs stably expressing the
indicated FLAG-RAD52-HA proteins were irradiated with γ-rays (8 Gy), and subjected to immunofluorescent staining
6 h after irradiation. Immunofluorescent images with anti-HA (green), anti-γH2AX (red), and anti-phospho-BRCA1
at Ser1524 (blue or white) antibodies are shown.
https://doi.org/10.1371/journal.pgen.1007277.g016
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Using this HR assay system, we first examined the impact of the depletion of RAD52,
RAD51, and BRCA2 proteins. These proteins were efficiently depleted by siRNA treatment
(S7C–S7G Fig). The depletion of RAD51 almost completely inhibited I-SceI-induced HR
repair, as expected (Fig 18B). The HR repair efficiency was reduced more by the BRCA2 deple-
tion than by the RAD52 depletion (S11 Fig), which is consistent with the notion that BRCA2
and RAD52 function in different pathways of RAD51-dependent HR repair [11]. Then, we
Fig 17. Effect of RAD52 (10xR) acetylation-deficient mutant protein on cell growth, cell survival and IR-induced
sister chromatid exchange. (A, B) T-Rex-293 (HEK293) cells stably expressing the Wt or 10xR FLAG-RAD52-HA
protein were cultured in the absence of the Tet inducer. (A) Endogenous RAD52 was depleted by siRNA treatment
with siRAD52 (3’UTR#1). Where indicated, the cells were also subjected to an siRNA treatment with the mixture of
siBRCA2 (#1, #2 and #3) at day 0. The cell growth was examined as described in the Supporting Materials and
Methods section. The graph shows the mean values and the standard error of the mean from triplicate samples.
Asterisks indicate statistically significant differences (, P<0.05 by t-test). (B) Cells were treated with the indicated
concentration of cisplatin. Cell survival was assayed as described in the Supporting Materials and Methods section.
Means with standard errors of four experiments are shown. Asterisks indicate statistically significant differences (,
p<0.001 by t-test). (C) T-Rex-293 (HEK293) cells stably integrated with pT-Rex-DEST30 containing FLAG-RAD52
(Wt)-HA, FLAG-RAD52 (10xR)-HA or its empty vector were cultured in the absence of the Tet inducer. The cells
were exposed to X-ray radiation. The sister chromatid exchange assay was performed, as described in the Materials
and Methods section. In independent experiments, 50 cells were counted for each condition. The graph shows the
mean values and the standard error of the mean from two independent experiments. Asterisks indicate statistically
significant differences (, P<0.05 by t-test).
https://doi.org/10.1371/journal.pgen.1007277.g017
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Fig 18. Acetylation of RAD52 is required for HR repair. (A) Schematic representation of the I-SceI-induced HR repair
assay. GFP-positive cells are produced by HR repair at an I-SceI-induced specific DSB site. (B) HeLa pDR-GFP cells were
treated with siRAD51 (#1), siRAD52 (CDS #1), siRAD52 (3’UTR #1) or negative siRNA control. (C) HeLa pDR-GFP cells
stably integrated with pT-Rex-DEST30 containing FLAG-RAD52 (Wt)-HA or FLAG-RAD52 (10xR)-HA were used. (D)
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examined the impact of the RAD52 acetylation-deficient mutation on HR repair (Fig 18C and
18D). We used two types of HeLa pDR-GFP cells, expressing either the HA-tagged RAD52
(Wt) or RAD52 (10xR) protein. The RAD52 (Wt) and RAD52 (10xR) proteins were expressed
by the native and CMV promoters, respectively, and the expression levels of the proteins were
almost the same in both types of cells (Fig 18E and S9F Fig). The endogenous untagged
RAD52 protein was depleted by a treatment with an siRNA targeted to the 3’UTR region of
RAD52 (S7C Fig). In both cell lines, the expression of the RAD52 (10xR) protein inhibited HR
repair (Fig 18C and 18D). Collectively, these findings demonstrate that the acetylation of
RAD52 is required for HR repair.
Acetylation mimic RAD52 (10xQ) mutation affects its protein-protein
interactions in yeast two-hybrid analysis
The interaction of human RAD52 with human RAD51 was previously detected in a yeast two-
hybrid analysis [15]. The interactions of yeast Rad52 with yeast Rpa1, Rpa2, Rpa3 and Rad51
have also been detected [14]. Therefore, we analyzed the interactions between the human acet-
ylation mimic RAD52 (10xQ) and its target-proteins, using a yeast two-hybrid analysis. Gluta-
mine (Q) is widely used to mimic acetylated lysine (K), because the effect of the lysine-to-
glutamine substitution is similar to the effect of the acetylation of lysine [48]. The yeast cells
lacked p300 and CBP. Therefore, we constructed the plasmids expressing either GAL4-DBD
or the NLS-GA4-AD-fused RAD52 (10xQ) mutant for a yeast two-hybrid analysis (S3 Fig).
When the NLS-GAL4-activation domain (AD)-fused protein interacts with the GAL4-DNA
binding domain (DBD)-fused protein, the reporter gene, His3, is expressed, and the yeast cells
show growth on an SC-Leu-Trp-His agar plate containing 25 mM 3-Amino-1,2,4-Triazole
(3AT). Interactions of the GAL4-DBD-fused human RAD52 (Wt) with the NLS-GA4-AD-
fused human RAD52 (Wt), RAD51, RPA1, RPA2 or RPA3 were observed in the yeast two-
hybrid analysis (S12 Fig). Another reporter gene, lacZ, can also be used in this yeast two-
hybrid analysis system. Therefore, we quantitatively examined the protein-protein interactions
of RAD52, by using a liquid β-galactosidase assay (Fig 19A–19E). Both RAD52 (Wt) and
RAD52 (10xQ) were expressed almost equally in yeast cells (Fig 19F). The self-interaction of
RAD52 was increased 1.7-fold by the 10xQ mutation (Fig 19A). The interactions of RAD52
with RAD51, RPA1, RPA2 and RPA3 were remarkably increased by the 10xQ mutation (Fig
19B–19E). These results suggest that the interactions of RAD52 with these proteins are
enhanced by its acetylation.
Discussion
Molecular Mechanisms Controlling HR through Human RAD52
Acetylation
Based on our findings, we propose the following working model (Fig 20). Following DSB for-
mation, human RAD52 and p300/CBP are recruited to DSB sites, and interact with each other
RAD52 (Wt or 10xR) knock-in HeLa pDR-GFP cells, as shown in S9 Fig, were used. (C, D) Cells were treated with siRAD52
(3’UTR #1) in order to deplete the non-tagged endogenous RAD52 protein. (B, C, D) After inducing I-SceI, GFP-positive cells
were examined as described in the Supporting Materials and Methods. Error bars indicate the standard error of the mean
from three samples (B, C) or twelve samples (D). (B) Asterisks indicate statistically significant differences of each protein-
depleted sample, as compared with the control (+I-SceI) (, P<0.05 and , P<0.01 by t-test). All samples connected by lines
were also compared. (C, D) Asterisks indicate statistically significant differences between Wt (+I-SceI) and 10xR (+I-SceI) (,
P<0.01 and , p<0.001 by t-test). (E) Immunoblotting analyses of RAD52-HA expression in the cells used in Panel C with
anti-HA and anti-GAPDH antibodies.
https://doi.org/10.1371/journal.pgen.1007277.g018
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Fig 19. RAD52 10xQ mutation affects protein-protein interactions in yeast two-hybrid analysis. (A) The β-galactosidase activities in the yeast two-
hybrid analysis were examined, as described in the Supporting Materials and Methods. (A) Interactions of GAL4 DBD-fused RAD52 with NLS-GAL4
AD-fused RAD52 (A), RAD51 (B), RPA1 (C), RPA2 (D) and RPA3 (E) were examined in yeast cells expressing the fused Wt or 10xQ RAD52 protein.
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near the DSB sites, thereby inducing RAD52 acetylation. Although 13 lysine residues can be
acetylated, the acetylation efficiency of each site is probably different. SIRT2 and SIRT3 are
also recruited to DSB sites shortly after DSB induction, and deacetylate RAD52. During HR,
RAD52 interacts with RPA or DNA. These interactions may prevent the ongoing acetylation
of RAD52 by p300/CBP. As a result, the acetylation level of RAD52 is diminished by SIRT2
and SIRT3. The acetylation sites of RAD52 are located in the DNA binding region (K133), and
also within regions involved in protein-protein interactions. Indeed, the acetylation-mimick-
ing RAD52 showed increased interactions with RPA and RAD51 in yeast cells (Fig 19B–19E),
and acetylated RAD52 binds ssDNA more robustly than non-acetylated RAD52 in vitro (S13
Fig). These findings suggested that acetylated RAD52 plays a critical role in the maintenance
of RAD51 recruited to DSB sites. Non-acetylated RAD52 dissociates prematurely from the
DSB sites, and thus impairs the retention of RAD51 at the DSB site and prevents the comple-
tion of HR. The change in the levels and sites of acetylation during HR might control several
activities of the multifunctional RAD52 protein.
HR is a multistep process mediated by the concerted actions of many proteins. Regulation
of each protein in both positive and negative manners is probably required to achieve the mul-
tistep and multi-enzyme processes. At present, the precise molecular mechanisms by which
RAD52 exerts its functions in HR have not been elucidated. It is possible, however, that the
strength of the RAD52 interactions with DNA and proteins could change during HR, which
would enable RAD52 to change interaction partners and act as a multifunctional protein.
Acetylation may provide important contributions to this regulation.
Function of Human RAD52 for RAD51 localization at DSB sites
Feng et al. demonstrated that the depletion of human RAD52 has small effects on decreasing
HR and IR-induced RAD51 foci formation, as compared to the depletion of human BRCA2
[11]. They also demonstrated, however, that the depletion of human RAD52 in a BRCA2-de-
pleted background further impairs both HR and RAD51 foci formation [11]. Based on these
observations, they proposed that two pathways lead to RAD51-dependent HR: One is a domi-
nant pathway in which BRCA2 mediates the recruitment of RAD51 to DSB sites, and the other
is a pathway in which RAD52 alternatively mediates RAD51 recruitment [11]. The latter path-
way becomes evident when the dominant BRCA2-mediated pathway is disrupted. Impor-
tantly, in the present study, non-acetylatable RAD52 impaired the localization of RAD51 foci
at DSB sites, even in the presence of the dominant BRCA2 pathway, suggesting that the non-
acetylatable RAD52 may competitively interfere with the BRCA2-mediated pathway. With
regard to the reduced co-localization of RAD51 with γH2AX, the acetylation-defective RAD52
10xR mutant may have a dominant-negative effect by binding to RAD51 and preventing the
localization of RAD51 at DSB sites. In the presently determined kinetics of RAD51 foci, the
RAD52 10xR mutant does not inhibit the initial step of RAD51 recruitment to DSB sites in the
presence of BRCA2. We suppose that RAD51 transiently accumulates and interacts with
RAD52 at DSB sites; however, RAD51 might subsequently dissociate from the DSB sites along
with RAD52 in this mutant. Here we have described the novel post-translational acetylation of
As a negative control, the empty vector used for the expression of GAL4 DBD-fused RAD52, pDEST32, was used. The relative β-galactosidase activities
compared to that of RAD52 (Wt) are shown. The graph shows the mean values and the standard error of the mean from at least three samples. Asterisks
indicate statistically significant differences (, p<0.001 by t-test). (F) Expression of the NLS-GAL4 AD or GAL4 DBD-fused RAD52-HA (Wt or
10xQ) proteins was analyzed by immunoblotting with an anti-HA antibody (upper and middle). In lane 1, the extract from yeast cells containing the
empty vector for the expression of the GAL4-DBD-fused protein was used. The same amounts of the yeast cell extracts used for the immunoblotting
analysis were also subjected to SDS-PAGE followed by CBB staining, for a loading control (lower). The immunoblotted bands of the 10xQ mutants
were slightly upshifted, as compared to those of the Wt, by the 10xQ mutation.
https://doi.org/10.1371/journal.pgen.1007277.g019
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Fig 20. Acetylation of human RAD52 is required for DSB repair by homologous recombination. A summary of our results is shown in the model (see discussion
in the main text).
https://doi.org/10.1371/journal.pgen.1007277.g020
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RAD52, and demonstrated that the failure to acetylate RAD52 critically impacts HR. Our
results suggest that an inhibitor of RAD52 acetylation could be exploited for anticancer
therapy.
Crosstalk between acetylation and phosphorylation at DSB sites
Our results demonstrated that DSB-induced RAD52 acetylation requires ATM kinase (Fig 20).
We also found that inhibiting the function of ATM caused a decrease in the accumulation of
RAD52 and p300/CBP at DSB sites. From these results, we drew the following hypothesis: In
the absence of DSBs, p300, CBP, and RAD52 are diffused in the nucleus. After DSB-induction,
these proteins accumulate at DSB sites, which will promote the interaction between RAD52
and p300 or CBP, thereby inducing the acetylation of RAD52. Accordingly, in the absence of
functional ATM, the interaction of RAD52 with p300 and CBP will not be promoted, leading
to the loss of acetylated RAD52.
Our findings revealed that the accumulation of SIRT2 and SIRT3 at DSB sites is also trig-
gered by ATM. Similar results were reported for the other HDAC, SIRT1, with ATM being
required for its accumulation at DSB sites [49]. Human RAD52 is phosphorylated by c-ABL,
and this phosphorylation is required for the IR-induced foci formation of RAD52 [29]. The
activation of c-ABL is induced in response to various types of DNA damage, including DSB,
and the activation depends on ATM. Therefore, ATM might be required for the IR-induced
foci formation of RAD52 at DSB sites through the c-ABL-mediated phosphorylation of
RAD52. ATM functions in the DNA damage-induced phosphorylation of p300 [41]. There-
fore, we examined whether ATM-mediated phosphorylation is required for the accumulation
of p300 at DSB sites, and concluded that p300 phosphorylation is dispensable for its accumula-
tion at DSB sites. To our knowledge, there are no reports that these HATs and HDACs possess
DNA binding activity. Therefore, it is unclear how they accumulate near DSB sites. One possi-
bility is that they are recruited to DSB sites via interactions with a protein that exists at DSB
sites. ATM phosphorylates several proteins at DSB sites. Taken together, our results suggest
that such an ATM-phosphorylated protein at DSB sites interacts specifically with several
HATs and HDACs, thereby recruiting them to DSB sites. In contrast to the requirement for
ATM in the accumulation of several HATs and HDACs at DSB sites, SIRT1 is required for the
accumulation of ATM at DSB sites [49]. Furthermore, ATM is also acetylated by another
HAT, Tip60 [50]. ATM acetylation enhances its activation as a protein kinase in response to
DNA damage. Thus, there is interplay between acetylation and phosphorylation in response to
DNA damage.
Conclusion
The roles of HATs and HDACs are important topics in many fields of biology and medicine.
In this paper, we found the novel roles of HATs (p300/CBP) and HDACs (SIRT2 and SIRT3)
in the HR process through the acetylation of human RAD52, indicating that human RAD52 is
required for HR, depending on its acetylation status. We further demonstrated that ATM pro-
tein kinase is required for DSB-induced RAD52 acetylation, as well as for the accumulation of
RAD52, p300/CBP, SIRT2, and SIRT3 at DSB sites. These findings indicate the presence of
crosstalk between acetylation and phosphorylation. Therefore, the ATM kinase activation/
RAD52 acetylation axis may be important for HR repair.
At DSB sites, several HATs and HDACs regulate histone acetylation, which is required for
DNA repair. In addition to histone acetylation, we have demonstrated that HATs (p300/CBP)
and HDACs (SIRT2 and SIRT3) directly regulate the acetylation of the non-histone protein,
RAD52. We speculate that HATs and HDACs target more DSB repair proteins at DSB sites.
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These findings provide important information for future studies using in vitro reconstitution
systems in the context of chromatin, to clarify the molecular mechanisms of DSB repair.
Materials and methods
Sister chromatid exchange assay
Confluent cells were exposed to X-rays at a dose rate of 1 Gy/min at room temperature. The
cells were immediately subcultured in media with bromodeoxyuridine (3 μg/ml). After adding
colcemid for 6 h, the cells were harvested and treated with a hypotonic KCl solution (75 mM)
at 37˚C for 20 min, followed by methanol:acetic acid (3:1) fixation. After three rounds of fixa-
tion, the cells were dropped onto slides. The slides were treated with Hoechst 33258 (10 μg/ml)
for 20 min and exposed to a black light for 30 min at 55˚C. Finally, the slides were treated with
2XSSC (saline sodium citrate) solution for 20 min at 65˚C. The slides were stained using 5%
filtered Giemsa solution mixed in Gurr. Images of metaphase cells were obtained using a Zeiss
Axioplan microscope (Carl Zeiss) equipped with a QImaging Exi Aqua Cooled CCD camera
(QImaging, Surrey, Canada). Sister chromatid exchanges were counted per chromosome.
Supporting information
S1 Text. Supporting Materials and Methods and Supporting References.
(PDF)
S1 Fig. Related to Fig 1. In vitro acetylation of human RAD52 by p300/CBP. (A) Physical
interaction of human RAD52 with p300. The RAD52 or GST protein was incubated with or
without FLAG-p300 in buffer P, and a pull-down assay was performed as described in the Sup-
porting Materials and Methods. Input or immunoprecipitated (IP) proteins were detected by a
mixture of anti-RAD52 and anti-GST antibodies (top) or an anti-FLAG (M5) antibody (bot-
tom). (B, C, D, F) In vitro acetylation assays were performed as described in the Supporting
Materials and Methods, using HAT buffer A containing sodium butyrate. Where indicated,
[14C]Ac-CoA was added. The reactions were analyzed by Coomassie Brilliant Blue staining
(left) or autoradiography (right). (B) RAD52 (3 μg), DNA polymerase β (3 μg), or BSA (3 μg)
was incubated with FLAG-p300 (2 μg) where indicated. (C, D) RAD52 (1.5 μg), RAD51
(1.5 μg), or DNA polymerase κ (1.5 μg) was incubated with 1 μg of CBP-FLAG (C) or FLAG-
p300 (D). (E) Silver staining of the RAD52, RAD51, DNA polymerase κ, FLAG-p300 and
CBP-FLAG proteins used in S1C and S1D Fig. (F) RAD52 (FL, 2 μg), RAD52 (N, 2 μg), or
RAD52 (C, 2 μg) was incubated with FLAG-p300 (1 μg), as indicated.
(PDF)
S2 Fig. Amino acid sequence alignment of RAD52 proteins. Alignment of RAD52 proteins
from Mus musculus (NCBI accession number AAA85794), Rattus norvegicus (NCBI accession
number NP_001100087), Cricetulus griseus (NCBI accession number NP_001233693), Homo
sapiens (NCBI accession number AAA85793), Pan troglodytes (NCBI accession number
JAA24777), Rhesus monkey (NCBI accession number AFH33435), Gallus gallus (NCBI acces-
sion number NP_001161231), and Xenopus laevis (NCBI accession number NP_001089585),
was performed using the Clustal 2.1 multiple sequence alignment program.
(PDF)
S3 Fig. Related to Fig 2. Schematic representation of RAD52 wild-type and acetylation-site
mutants used in this study. Mutations were introduced in functional domains, such as the
highly conserved region (K133R, K133/K177R), the RPA binding region (K262R), and the
RAD51 binding region (K323R), and also introduced outside the domains (190/192R). The
Acetylation of RAD52 in homologous recombination
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007277 March 28, 2018 32 / 38
13xR and 11xR mutants contain multiple mutations including the NLS sequence, whereas the
acetylation sites in the NLS sequence are normal in the 10xR and 8xR mutants. The NLS
sequence is conjugated at the N-terminal in NLS-RAD52 (Wt) and NLS-RAD52 (13xR). The
10xQ mutant contains multiple glutamine (Q) substitutions at the same mutated sites as in the
10xR mutant.
(PDF)
S4 Fig. Related to Fig 2. ssDNA binding activity of the RAD52 11xR mutant. (A) Electro-
phoretic mobility shift assay (EMSA) was performed using a 50-mer oligonucleotide (10 μM in
nucleotides) with a Cy5 dye attached to the 5’ end (oligo 1), and the indicated concentrations
of RAD52 or the RAD52 11xR mutant. (B) Percentages of ssDNA bound by RAD52 (open cir-
cles, blue) and the RAD52 11xR mutant (open triangles, green) as a function of the protein
concentration.
(PDF)
S5 Fig. Related to Fig 3. Human RAD52 is acetylated by p300/CBP in vivo. (A) Acetylation
of the FLAG-RAD52-HA protein purified from T-Rex-293 (HEK293) cells was detected as
described in the Supporting Materials and Methods, using the indicated antibodies. pRc/
RSV-CBP-HA was transfected into cells, and FLAG-RAD52-HA was purified from cell
extracts 24 h after transfection. (B, C) MRC5V1 cells were transfected with the expression plas-
mid for HA-p300 (B) or CBP-HA (C), and were unirradiated or irradiated with γ-rays (8 Gy)
at 24 h after the transfection. At the indicated time after irradiation, the cells were subjected to
immunofluorescent staining with an anti-HA (green) antibody, an anti-γH2AX (red) anti-
body, and 4’,6-diamidino-2-phenylindole (DAPI, blue). (D, E) T-Rex-293 cells expressing
Myc-RAD52 were transfected with the expression plasmid for HA-p300 (D) or CBP-HA (E),
and were irradiated with γ-rays (8 Gy) at 24 h after the transfection. At the indicated time after
irradiation, the cells were subjected to immunofluorescent staining with anti-HA (green) and
anti-Myc (red) antibodies. (F, G) DSP-mediated cross-linking experiments were performed in
the presence or absence of doxorubicin, as described in the Supporting Materials and Methods.
RAD52-HA or GST-HA was expressed, as indicated. Whole cell extracts (WCE; left panel) or
immunoprecipitates (IP; right panel) with anti-p300 (F) or anti-CBP (G) antibodies. (H, I)
T-Rex-293 cells expressing FLAG-RAD52-HA were transfected with either a negative control
siRNA or mixture of p300 and CBP-specific siRNAs. Cell extracts were subjected to immuno-
blotting analyses with the indicated antibodies. (A, H, I) The relative band intensities normal-
ized to those of the HA or GAPDH bands are shown below the immunoblots.
(PDF)
S6 Fig. Related to Figs 3 and 7. Immunostaining of empty expression vector containing
cells with acetylated RAD52 antibody. T-Rex-293 cells containing the empty pT-Rex-
DEST30 vector were irradiated with γ-rays (8 Gy). At 1 hour after irradiation, the cells were
subjected to immunofluorescent staining with an anti-γH2AX antibody (red), an anti-acety-
lated RAD52 at K323 antibody (blue or white), and DAPI (blue).
(PDF)
S7 Fig. Related to Figs 7, 15, 17, and 18. Confirmation of siRNA-mediated knockdown.
T-Rex-293 (A, B), HEK293 (C, E) or HeLa pDR-GFP (D, F, G) cells were transfected with the
negative control (shown by “C”) or the indicated siRNA, as described in the Supporting Mate-
rials and Methods. The mixture of siRAD52 (CDS#1, CDS #2 and CDS #3), the mixture of
siRAD51 (#1 and #2), and the mixture of siBRCA2 (#1, #2 and #3) were used in panels D, F,
and G, respectively. Whole cell extracts (A, B, C, E and F) or total RNA from the cells (D and
G) were prepared 72 h after siRNA transfection, and were subjected to immunoblotting (A, B,
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C, E and F) and RT-PCR (D and G) analyses, respectively.
(PDF)
S8 Fig. Related to Figs 11, 12 and 13. ATM inhibition does not affect cellular protein levels
of RAD52, p300, CBP, SIRT2 and SIRT3. (A-E) Cell extracts prepared under the same exper-
imental conditions as in Figs 11E, 12A, 12B, 13A and 13B were subjected to immunoblotting
analyses, using the indicated antibodies. The relative band intensities normalized to those of
the GAPDH bands are shown in the graphs. The graphs show the mean values and standard
errors of the mean from 3–7 independent experiments (N.S., not significant by t-test).
(PDF)
S9 Fig. Related to Figs 15 and 18. CRISPR-Cas9-mediated genome editing. (A) The donor
plasmid DNA used for the CRISPR-Cas9-mediated knock-in of FLAG and the HA-tagged
RAD52 coding sequence (CDS) into the genomic region of the targeted RAD52 gene. Multisite
Gateway technology was used for the construction of the donor plasmid DNA, as described in
the Supporting Materials and Methods. (B, C, D, E) PCR analysis of knock-in HeLa pDR-GFP
and HEK293 cells. (B, C) The DNA sequences of the forward (P1) and reverse (P2 and P3)
primers used in the PCR analysis are described in the Supporting Materials and Methods. The
primers P1, P2 and P3 anneal the genomic DNA region upstream from the start codon of the
RAD52 gene, the SV40 polyA region from pT-Rex-DEST30, and the intron region of RAD52,
respectively. (D, E) Agarose gel electrophoresis of the PCR products. The genomic DNAs puri-
fied from HeLa pDR-GFP (D) and HEK293 (E) knock-in cells were analyzed by PCR with the
indicated primers. As controls, genomic DNAs from untargeted cells were used in lane C. (F,
G) Whole cell extracts of the HeLa pDR-GFP (F) and HEK293 (G) knock-in cells were sub-
jected to immunoblotting analyses with the indicated antibodies.
(PDF)
S10 Fig. Related to Fig 9. Effect of acetylation-deficient mutations on ionizing radiation-
induced foci formation of RAD52 expressed by the native promoter. (A) RAD52 (Wt or
10xR) knock-in HeLa pDR-GFP cells, as shown in S9 Fig, were used. The cells expressing HA-
tagged RAD52 proteins by the native promoter were treated with siRAD52 (3’UTR #1) in
order to deplete the untagged endogenous RAD52. Two days after the siRNA treatment, the
cells were unirradiated or irradiated with γ-rays (8 Gy). At the indicated time after irradiation,
the cells were subjected to immunofluorescent staining with an anti-HA (green) antibody, an
anti-γH2AX (red) antibody, and DAPI (blue). (B) The percentages of RAD52 foci colocalized
with γH2AX at 6h after irradiation were calculated, as described in the Supporting Materials
and Methods. Error bars indicate the standard error of the mean. Asterisks indicate statistically
significant difference between Wt and 10xR (, p<0.001 by t-test).
(PDF)
S11 Fig. Related to Fig 18. Comparison of knockdown effects on HR repair between
RAD52 and BRCA2. HeLa pDR-GFP cells were transfected with the control or indicated
siRNA, and were subjected to the DR-GFP assay as described in the Supporting Materials and
Methods. In the column labeled siBRCA2 (mix), the mixture of siBRCA2 (#1, #2 and #3) was
used. For RAD52 depletion, siRAD52 (CDS #1) was used. Error bars indicate the standard
error of the mean from three samples. Asterisks indicate statistically significant differences of
each protein-depleted sample, as compared with the control (+I-SceI) (, P<0.01 by t-test).
The samples connected by lines were also compared.
(PDF)
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S12 Fig. Related to Fig 19. Interactions of human RAD52 with human RAD52, RAD51 and
RPA subunits by a yeast two-hybrid analysis. Yeast MAV203 cells were transformed with
expression vectors encoding the indicated NLS-GAL4-activation domain (AD)- and
GAL4-DNA binding domain (DBD)-fused proteins. As controls, the empty vector for the
expression of the GAL4-DBD fusion protein was used (1–5). The negative control (C1) and
positive controls (C2 and C3) were also included. Each transformant was examined for growth
on an SC-Leu-Trp agar plate and an SC-Leu-Trp-His agar plate containing 25 mM 3-Amino-
1,2,4-Triazole (3AT).
(PDF)
S13 Fig. ssDNA binding activity of in vitro acetylated RAD52. (A) EMSA was performed
using a 50-mer oligonucleotide (10 μM in nucleotides) with a Cy5 dye attached to the 5’ end
(oligo 1), and the indicated concentrations of RAD52 or acetylated RAD52. (B) Quantification
of (A). Percentage of ssDNA bound by RAD52 (open circles, blue) and acetylated RAD52
(open squares, red) as a function of protein concentration. Error bars indicate standard devia-
tion (n = 3).
(PDF)
S1 Table. Mascot search results of tryptic-peptide fragment of acetylated RAD52 (FL).
(PDF)
S2 Table. Mascot search results of Asp-N peptide fragment of acetylated RAD52 (FL).
(PDF)
S3 Table. Mascot search results of peptide fragment of acetylated RAD52 (N).
(PDF)
S4 Table. Mascot search results of peptide fragment of acetylated RAD52 (C).
(PDF)
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